VIANEWS –

Shares of Pacific Biosciences of California (PACB) rose 7.24% to $31.32 at 14:19 EST on Wednesday, after two sequential sessions in a row of gains. NASDAQ Composite (PACB) is rising 0.64% to $14,592.02, following the last session’s upward trend. This seems, up to now, a somewhat up trend trading session today.

Pacific Biosciences of California’s last close was $29.20, 45.61% under its 52-week high of $53.69.

Volume

Today’s last reported volume for Pacific Biosciences of California is 2533862 which is 3.21% above its average volume of 2455104.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 75% for the present quarter and 68.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 33.3% and a negative 50%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 92.29M for the twelve trailing months.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current volatility was a negative 0.40%, a negative 0.51%, and a positive 3.31%, respectively.

Pacific Biosciences of California’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.29% (last week), 3.22% (last month), and 3.31% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be oversold (<=20).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $31.32 at 14:20 EST, way below its 52-week high of $53.69 and way above its 52-week low of $3.57.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s value is higher than its 50-day moving average of $30.08 and below its 200-day moving average of $31.85.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here